Neurobiology of retinal dopamine is reviewed and discussed in relation to degenerative states of the tissue. The Introduction deals with the basic physiological actions of dopamine on the different neurons in vertebrate retinae with an emphasis upon mammals. The intimate relationship between the dopamine and melatonin systems is also covered. Recent advances in the molecular biology of dopamine receptors is reviewed in some detail. As degenerative states of the retina, three examples are highlighted: Parkiuson's disease; ageing; and retinal dystrophy (retinitis pigmentosa). As visual functions controlled, at least in part, by dopamine, absolute sensitivity, spatial contrast sensitivity, temporal (including flicker) sensitivity and colour vision are reviewed. Possible cellular and synaptic bases of the visual dysfunctions observed during retinal degenerations are discussed in relation to dopaminergic control. It is concluded that impairment of the dopamine system during retinal degenerations could give rise to many of the visual abnormalities observed. In particular,
INTRODUCTION
Dopamine (DA), a biogenic amine synthesized from tyrosine by the enzyme tyrosine hydroxylase (TH), has fully been established to function as a major neurotransmitter or modulator in vertebrate retinae (Ehinger, 1983; Nguyen-Legros, 1988; Djamgoz & Wagner, 1992; Witkovsky & Dearry, 1992; Djamgoz, Wagner & Witkovsky, 1995b; Marc, 1995) . The cellular localization, modes of action and possible visual roles of DA are quite consistent across vertebrates, from fish to primates, implying that DA has a rather conserved role in visual processing. From an experimental point of view, this has resulted in work done on lower vertebrates (e.g. fish, amphibia, reptiles) being applicable, at least in principle, to the human situation, enabling clinically relevant questions to be asked and possible therapeutic routes investigated using model systems. Although some differences have also been observed, it i,; not always clear whether these are truly due to species difference or to the extent of retinal DA loss in experimental animals. The main purpose of this article is to review the neurobiology of retinal DA in relation to disease states involving degeneration of the tissue. As regards the latter, three conditions have been highlighted:
1. Parkinson's disease (PD); 2. ageing; and 3. retinitis pigmentosa (RP).
On the basic neurobiology side, some emphasis has been placed upon mammalian systems. However, as already noted, since research on lower vertebrates has contributed greatly to our understanding of visual functions subserved by retinal DA, information obtained from vertebrates generally has been included. Furthermore, since such understanding and future design of therapeutic methods would not be complel~e without an in-depth knowledge about the molecular b!iology of DA receptors, this topic has also been given prominence.
Although we have reviewed specifically the retinal components of the visual dysfunctions associated with the three different neuro-degenerations, it is certain in the cases of PD and normal ageing (as well as Alzheimer's disease) that central defects also occur. In fact, the latter are central to the diseases in question. Caution must be 3509 exercised, therefore, in seeking to correlate clinically (e.g. psychophysically) characterized visual symptoms with retinal activity. In order to measure the latter, two types of electroretinographic recording have mostly been used:
Pattern electroretinogram (PERG) which is thought
to represent post-receptoral, and possibly ganglion cell, responses in the inner retina (e.g. Maffei, Fiorentini, Bisti & Hollander, 1985; Zrenner, 1990 ). 2. Flash electroretinogram (FERG) which is due mainly to activity in the outer retina, the b-wave reflecting centre-depolarizing (ON-) bipolar cell current flowing through Muller cells (Kline, Ripps & Dowling, 1978; Ikeda, 1987; Celesia & Tobimatsu, 1990; Falk & Shiells, 1995) .
On the other hand, visually-evoked potentials (VEPs) in general represent the arrival ot the visual signals at the cortex.
Neurobiology of retinal dopamine: an overview
In vertebrate retinae, DA is contained in amacrine (AC) and/or interplexiform cells (IPCs) . A comparative study on fish found that ACs occur in species with all-rod retinae whilst IPCs are found in duplex retinae (Frohlich, Negishi & Wagner, 1995) . The situation in higher vertebrates is less certain; for example, the rat retina, which is rod-dominant, has IPCs (Negishi, Teranishi & Kato, 1985) . On the whole, in fact, IPCs appear to be a general feature of the retinae of mammals (NguyenLegros, 1988) , including humans (Frederick, Rayborn, Laties & Hollyfield, 1982) . Interestingly, dopaminergic neurons also contain GABA (e.g. W~issle & Chun, 1988) , but the functional consequence of this co-existence is not known. Dopamine is released in the retina during light adaptation in a Ca2+-dependent manner and can reach extracellular concentrations of some 800 nM (Witkovsky, Nicholson, Rice, Bohmaker & Meller, 1993) . Release of DA is under the inhibitory control of D2-type autoreceptors and a number of independent neurochemical systems (Table 1) . Furthermore, in the chick retina DA has been shown to stimulate K + efflux which could lead to a variety of secondary effects (Laitinen, 1993) . Importantly, irrespective of its cellular origin(s), DA can diffuse over distances of up to 3 mm, that is, the entire retinal thickness, giving rise to so-called "volume transmission" (Yazulla & Studholme, 1995) . Thus, every type of retinal neuron may be influenced by DA, whether in synaptic contact or not. The main physiological effects of DA on the different neurons of the retina are as follows.
Photoreceptors. Dopamine has been shown to induce photomechanical movements in fish and amphibia, consistent with an involvement in the light adaptation process (Pierce & Besharse, 1985; Dearry & Burnside, 1986) . Disc shedding, which occurs in all vertebrates and is known to be essential for healthy photoreceptor function and survival, is inhibited by DA (Besharse, Iuvone & Pierce, 1988) . Both retinomotor :movement and disc shedding involve the D2 family of receptors. There is limited data as regards possible electrophysiological effects of DA on photoreceptors, although iindirect effects involving second-order neurons clearly occur (Witkovsky & Dearry, 1992) . For example, DA has been found to suppress the "rollback" effect in the lightevoked responses of goldfish cones (Hedden & Dowling, 1978) and enhance the flicker response of amphibian rods (Krizaj & Witkovsky, 1993) , both of which could be explained as consequences of secondary actions involving the horizontal cells. In a recent study, Akopian and Witkovsky (1996) showed that activation of D2 receptors on Xenopus rod photoreceptors resulted in inhibition of a hyperpolarization-activated current and it was suggested that this effect could reduce the ability of rods to signal time-modulated visual stimuli.
Horizontal cells. In order to interpret the pathophysiological data from degenerating retinae, it is important to understand some of the background physiology and the responses to exogenous applications of DA and selective DA antagonists in the normal adult mammalian retina. One important characteristic of horizontal cells (HCs) in all vertebrates is their extensive receptive field properties. Thus, single HCs respond to light stimuli presented well beyond their individual dendritic tree. The origin of this expansive summation lies in the extensive gap-junction coupling between adjacent HCs of a given functional class (Yamada & Ishikawa, 1965; Naka & Rushton, 1967) . The DA pathway plays a role in shaping the receptive field properties of HCs by uncoupling the electrotonic junctions between adjacent cells in verte- 
The typical dose dependent actions of dopamine and (B) the D1 receptor group antagonist SCH 23390 on the dark-resting membrane potential and the light-evoked S-potentials of rod-driven horizontal cells in the normal adult rat retina. The recordings show the transmembrane potential (Em) of single cells recorded in isolated and superfused preparations. Each downward deflection on the resting membrane potential represents a hyperpolarizing S-potential response to a full-field light stimulus (4 mm diameter;/l = 520 nm). The drugs, dissolved in the superfusate, were applied at the times indicated by the bars beneath the recordings. (A) 2 and 10 #M dopamine (IDA) evoked a dose related depolarization associated with a significant reduction in the full-field light response. The effects were fully reversed following washout. (B) 10 and 100#M SCH 23390 (SCH) evoked dosedependent hyperpolarizations accompanied by a significant enhancement of the full-field light response. (C) The effect of the D1 antagonist SCH23390 (SCH) on the response of horizontal cells to exogenous DA. Note that both the depolarization and the reduction in the amplitude of the light response evoked by 10 pM DA were effectively" reversed by the coapplication of 10 pM SCH 23390.
Thus, on the whole, DA has two main distinct effects upon HC function (Djamgoz & Wagner, 19'92; Witkovsky & Dearry, 1992) . First, it potentiates the: glutamatergic photoreceptor input to the cells, giving rise to resting membrane depolarization and reducing light-evoked response amplitude in the intact retina (Hedden & Dowling, 1978; Knapp & Dowling, 1987; Hankins & Ikeda, 1991) . Second, it weakens the gap junctions that usually couple the HCs (Teranishi, Negishi & Kato, 1983; Piccolino, Neyton & Gerschenfeld, 1984) . Both effects are mediated by D1 receptors with cAMP as the second messenger, activating protein kinase A to phosphorylate kainate receptors and connexons, respectively (Lasater & Dowling, 1985; Lasater, 1987) . Further effects on HCs have been described whereby DA was shown: (i) to suppress GABAc receptor activity in the catfish (Dong & Werblin, 1994) ; and (ii) to potentiate the activity of sustained Ca 2+ channels in the white bass (Pfeiffer-Linn & Lasater, 1996) . Since GABAc receptors are thought to have a facilitatory (i.e. positive) autofeedback role (Djamgoz, 1995) , DA would suppress GABA release in the retina (Yazulla & Kleinschmidt, 1982; Yazulla, 1985) .
The effects of DA on HCs would be expected to result in profound changes in the visual process. The uncoupling of HCs could ultimately lead to loss of spatial vision as well as impairment of temporal sensitivity as a result of suppression of HC-photoreceptor negative feedback. In addition, there may be further effects involving absolute sensitivity and colour vision. As regards the latter, there appear to be significant differences in cone connectivity and spectral opponency of mammalian (including primate) HCs, and hence the retinal mechanisms of chromatic processing (Dacey, 1996; Dacey et al., 1996; Paulus & Kroger-F'aulus, 1983) .
Nevertheless, since DA clearly modulates cone ~ HC transmission and there is some spectral selectivity in cone-HC connectivity (e.g. Ahnelt & Kolb, 1994) , defects in chromatic processing could result in species with DA-depleted retinae.
Bipolar cells. Dopamine appears to have both direct and indirect effects upon bipolar cells (BCs), the latter occurring mainly via HCs (Hedden & Dowling, 1978) . Accordingly, the uncoupling of HCs would enhance the "centre" responses of BCs (Hedden & Dowling, 1978) . In addition, there may be a direct effect on BCs, as DA has been found to enhance a glutamate-gated ionic current in solitary OFF-BCs of the tiger salamander retina (Maguire & Werblin, 1994) . Furthermore, Wellis and Werblin (1995) showed that DA modulates GABAc receptors mediating inhibition of voltage-activated Ca 2+ entry into and transmitter release from BC termin~Js in a slice prepartion of the tiger salamander retina. In the all-rod retina of dogfish, DA hyperpolarized ON-BCs and reduced their light-evoked responses without affecting the membrane potential or the light-evoked responses of HCs (Shiells & Falk, 1985) . Experiments investigating the possible effect of depleting retinal DA on the electroretinographic b-wave gave inconsistent results. A decrease in b-wave amplitude has been found in chicken (Li, Schaeffel, Krhler & Zrenner, 1992) and frog (Citron, Erinoff, Rickman & Brecha, 1985) . In humans also, DA receptor blockers (chlorpromazine and fluphenazine) reduced the b-wave amplitude (Holopigian, Clewner, Seiple & Kupersmith, 1994) . On the other hand, the effect of retinal DA depletion was the opposite in cat (Skrandies & W~issle, 1988) and rabbit (Oliver, Jolicoeur, Lafond, Drumheller & Brunette, 1986) , whilst no effect was seen in goldfish . Possible species differences aside, these results suggest that DA may indeed have a variety of effects upon BC sensitivity in the outer retina. Amacrine cells. Amacrine cells (ACs) are a very diverse population of neurons in several different respects (morphology, physiology, neurochemistry etc.). The main effect of DA on ACs is the uncoupling of electrotonic junctions linking some ACs. In the mammalian retina, one such AC is the AII type, which receives the majority of the dopaminergic input in the inner plexiform layer (IPL) and are coupled by gap junctions both to other AII ACs and to cone BCs, thus integrating rod-cone activity in the inner retina (Daw, Jensen & Brunken, 1990) . Dopamine and cAMP agonists suppress AII-AII AC coupling, but not AII-BC coupling (Mills & Massey, 1995) . The latter, which appeared to be relatively weaker, was selectively reduced by nitric oxide (NO) and cGMP agonists (Mills & Massey, 1995) . Interestingly, DA was found not to affect the coupling of transient ACs in the carp retina (Teranishi & Negishi, 1994) .
Ganglion cells. Our knowledge of the physiology of ganglion cells (GCs) is far from complete. Depending on their synaptic inputs, GCs may generally be classified as "simple" and "complex" reflecting dominant BC and AC inputs, respectively (Dowling, 1987) . In turn, the latter may be sensitive to movement, including its direction (Barlow & Levick, 1965) or stimulus orientation (Levick, 1967) . Whilst BC ~ GC transmission is mainly excitatory (Naka, 1977) , AC input(s) to GCs can be excitatory or inhibitory (Dowling, 1987) . There is considerable evidence to suggest that DA is involved in the physiological ("dark" and "light") activities of GCs in mammalian retinae [see Djamgoz & Wagner (1992) for an extensive review]. Liu and Lasater (1994) have shown that DA, acting via DI receptors, modulates (mainly reduces) voltage-gated Ca 2+ channels in turtle GCs and could thus affect the cells' spiking behaviour. In rabbit and cat retinae, the role of endogenous DA in GC activity has been studied using DA antagonists (Jensen & Daw, 1983 , 1984 , 1986 Maguire & Hamasaki, 1994; Ikeda, Priest, Robbins & Wakakuwa, 1986 ) and 6-OHDA treatment (Maguire & Smith, 1985) . Thus, in DAdepleted retinae on the whole the following effects were seen.
1. The spontaneous ("dark") activity of OFF-centre GCs was decreased whilst the effect was the opposite in ON-centre GCs. Thus, both effects suggested a reduction of contrast between light-and dark-evoked activities. 2. There was a clear suppression of light-evoked responses of OFF-centre GCs (cat; Maguire & Hamasaki, 1994) . 3. The excitatory response of ON-centre GCs was converted to OFF-like sustained inhibition (rabbit; Jensen & Daw, 1986) .
The sites of endogenous DA action were mainly presynaptic and involved D1 receptors distributed rather diffusely in the IPL (Elena, Denis, Kosina-Boix & Lapalus, 1989; Denis, Elena, Nordmann, Saraux & Lapalus, 1990; Ariano, Kang, Haugland & Sibley, 1991; Behrens & Wagner, 1995) .
Interestingly, there could be D2-1ike receptors on GC somata in the adult cat retina but these were unlikely to be influenced by endogenous DA (Ikeda et al, 1986) . On the other hand, synaptic D2 receptors appeared to have a functional role, application of D2 ago:nists generally having the same effects as D1 antagonists (Jensen & Daw, 1988) . Furthermore, blockade of [)2 receptors in humans and monkeys affected the PERG, as detailed in the section dealing with PD (Stanzione, Pierantozzi, Semprini, Tagliati, Traversa, Peppe, Piere, lli & Bernardi, 1995; Tagliati, Bodis-Wollner, Kovanecz & Stanzione, 1994) . Finally, any technical difference in these studies aside, the balance in the antagonistic relationship between D1 and D2 receptors has been suggested to be instrumental in determining the profiles of visual functions controlled by DA (Bodis-Wollner & Antal, 1995b) .
In conclusion, the available data taken together would suggest that DA is involved in modulating the "through" pathway of signal transmission, as wel]t as the lateral systems of HCs and ACs, and hence the output of the retina. In addition, certain GCs in the mammalian retina may use DA as their neurotransmitter to communicate with central visual areas (Simon & Nguyen-Legros, 1995) .
Relation between dopamine and melatonin pathways
In the retinae of numerous species, including man, melatonin (MEL) synthesis is confined almost exclusively to photoreceptors (Wiechmann & Hollyfield, 1988) . Ultimately, the rate of MEL synthesis governs the level of its release in the retina (Redburn & Mitchell, 1989) . The rate of synthesis is inhibited by light since N-acetyl-transferase (NAT), one of the rate-limiting enzymes in the synthesis of MEL, is not only inhibited by cAMP but is also Ca 2+ dependent (Iuvone & Besharse, 1986) . Furthermore, it has recently been shown that in the pineal gland the production of NAT-mRNA itself is strictly regulated according to the diurnal cycle and is acutely suppressed in light (Boljigin, Wang & Snyder, 1995) . It has also been shown that in the absence of normal ambient light cues, the daily rhythm of MEL synthesis persists (Cahill & Besharse, 1993; Tosini & Menaker, 1996) , suggesting that a local circadian oscillator resides within the retina itself. Functionally, . r Affinity of D5 for dopmnine is higher than D I, gDopamine has a similar affinity tbr D2 and D4, whereas it has a relatively higher affinity for D3. hD3 and D4 receptors generally display similar affinities for agonists and antagonists. Quinpirol (agonist), AJ76 (antagonist) and UH232 (antagonist) have been reported to be more selective for D3. It has been suggested that clozapin is a selective antagoni,;t for D4.
MEL is principally established as a potent inhibitor of light-dependent retinal DA release (Dubocovich, 1983) , whilst conversely, DA inhibits MEL release through its action at photoreceptor D4 receptors (Cohen, Todd, Harnaon & O'Malley, 1992) . Based upon evidence such as this, a functional hypothesis has emerged that retinal DA and MEL pathways perform contra-regulatory roles in retinal light/dark activity (Morgan & Boelen, 1996) . In the mammalian retina, at least, there is strong evidence that the dopaminergic pathways are chiefly active in the light-or day-period (Godley & Wurtman, 1988; Dong & McReynolds, 1991; Djamgoz & Wagner, 1992) , and are thus implicated in the physiological transition to conemediated vision. Release of DA in the retina is further controlled, directly or indirectly, by a variety of neurochemical systems, as summarized in Table 1 , a major inhibitory influence being exerted by GABA.
Molecular neurobiology of dopamine receptors
Dopamine receptors belong to the guanine nucleotidebinding regulatory (G-) protein coupled receptor superfamily. Originally, DA receptors were divided into D1 and D2 receptors based on their pharmacological characteristics and biochemical interaction with the plasmamembrane bound enzyme, adenylyl cyclase, activation of which generates cAMP as a second messenger (Kebabian & Calne, 1979) . Thus, D1 receptors stimulated adenylyl cyclase whilst D2 receptors were inhibitory or not associated. Although five main DA receptor subtypes have subsequently been identified in vertebrates, the basic division into Dl-like and D2-1ike receptors still seems to hold (Sokoloff & Schwartz, 19951) (Table 2) . With the development of modern techniques of molecular biology, >30 DA receptor subtypes have, in fact, been cloned and sequenced from various species. Figure 2 shows a hypothetical phylogenetic tree for all presently known DA receptors (see also Hirano, Archer & . The phylogenetic analysis is not the most definitive way to classify the functional receptor subtypes, as this is modified continuously as new sequences are added. However, it shows a clear distinction between receptor subtypes and species homologues [reviewed by Vernie, Cardinand, Valdenaire, Philipe & Vincent (1995) ]. Hydropathy analysis, and structural similarities with the extensively characterized bacteriorhodopsin suggest that all of the DA receptor subtypes contain seven hydrophobic domains which are most likely to be transmembrane regions. These are characteristic of G-protein coupled receptors with the receptor Nterminus in the extracellular space and the (;-terminus on the cytoplasmic side of the membrane (Henderson & Schertler, 1990; Trumpp-Kallmryer, Hoflack, Bruinvels & Hibert, 1992) .
D1 receptors. Two subtypes of Dl-like receptors have been cloned and their pharmacological and biochemical properties have been determined. The first sub-type was cloned from human and was referred to as D1 (later, also as D1A) (Dearry et al., 1990; Sunahara eta,!., 1990; Zhou et at., 1990) . The second subtype, also identified first in human, has been referred to as the D5 or D1B receptor . There have been >10 species homologues in vertebrates all together (Fig. 2) . D1/D1A receptor and D5/DIB receptor genes in humans encode proteins of 446 and 477 amino acids, respectively. Although both genes are intronless in the coding region, an intron in the 5' non-coding region of tile human DI/ D1A receptor gene has been reported (Minowa, Minowa, Monsma, Sibley & Mouradian, 1992) and two pseudogenes of the D5/D1B receptor have been found in human genome (Grandy, Zhang, Bouvier, Zhou, Johnson, Allen, Buck, Bunzow, Salon and Civelli, 1991) .
Recently, novel Dl-like receptors, D1C (Sugamori et at., 1994) and DID (Demchyshyn et al., 1995) FIGURE 2. A hypothetical phylogenetic tree for dopamine receptor subtypes. This tree was generated by using a software package LASERGENE, based on an amino acid sequence alignment of the receptors. All sequences were aligned using the Clustal method with the PAM 250 weight table. The length of the horizontal lines in the tree correspond to sequence divergence. Phylogenetic classification of receptor subtypes is shown on the right side of the tree. For subtypes with isoforms reported (see text), the sequence of the longer isoform was chosen for the alignment. The rat fl 1-adrenoceptor was used in the alignment to provide an outgroup. Sequence sources are as follows: Dl/D1A--human (Dearry et al., 1990) ; monkey (Machida, Searles, Nipper, Brown, Kozell & Neve, 1992) ; pig (Grenader, O'Rouke & Healy, 1995) ; rat (Zhou, Li & Civelli, 1992) ; opossum (Nash, Godinot & Carom 1993) ; chicken (Demchyshyn et al., 1995) ; Xenopus (Sugamori et al., 1994) ; fugu (D14) (Macrae & Brenner, 1995) ; eel (Hirano et al., 1997) ; carp (Hirano et al., 1997) ; goldfish (Frail et al., 1993) ; D5/D1B--rat (Tiberi, Jarvie, Silvia, Falardeau, Gingrich, Godinot, Bertrand, Yang-Feng, Fremeau & Caron, 1991) ; human , chicken (Demchyshyn et al., 1995) , Xenopus (Sugamori et al., 1994) , eel (Hirano et al., 1997) ; D1C fugu (DL) (Macrae & Brenner, 1995) , tilapia (direct submission to GenBank, X81969), Xenopus (Sugamori et al., 1994) ; DID---chicken (Demchyshyn et al., 1995) ; D2/D2A--African green monkey (Thurfkauf, Hutchison, Peterson, Cornfield, Meade, Huston, Hams, Ross, Gerber & Ramabhadran, 1995) , human (Selbie et al., 1989) , cow (Chio et al., 1990) , mouse (Montmayeur et al., 1991 ) , rat (Monsma et al., 1989) Xenopus (Sugamori et al., 1994) , fugu (D215) (Macrae & Brenner, 1995) ; D3/D2B--African green monkey (direct submission to GenBank, U21307), human (Griffon et al., 1996) , mouse (Fishburn et al., 1993) , rat , fugu (D222) (Macrae & Brenner, 1995) ; D4/D2C--mouse (Fishburn, Carmon & Fuchs, 1995) , rat (O'Malley, Harmon, Tang & Todd, 1992) , human , carp (Hirano et al., 1997) ; rat fll-adrenoceptor (Shimomura & Terada, 1990 ).
cyclase activity (Sugamori et al., 1994) . Two Dl-like receptor genes, referred to as D14 and DL, have also been cloned from the puffer fish (Macrae & Brenner, 1995) . Phylogenetic analysis has shown that D1C and DL form a related group whilst DID appears in a unique branch (Fig. 2) . Multiple D l-like receptors might exist also in mammals. D2 receptors. Within the mammalian D2-1ike receptor group, three subtypes have been identified, as follows: D2/D2A (Bunzow et al., 1988; Dal Toso et al., 1989; Giros et al., 1989; Grandy et al., 1989; Matsumoto et al., 1995) . Furthermore, several species homologues have been reported in vertebrates as a whole (Fig. 2) . Amino acid sequences of these receptors show higher similarities among D2-1ike receptors than D l-like receptors. The third cytoplasmic loop is likely to be an important domain for the interaction with G-protein and there is a distinct difference in this region between D1-like and D2-1ike receptors (Neve, Henningsen, Kozell, Cox & Neve, 1994) . Dl-like receptors (D1/D1A, D5/ D1B, DIC and DID) display a short third cytoplasmic loop, whereas D2-1ike receptors (D2, D3 and D4) have a long loop in this domain (Sokoloff et al., 1994) . Also, the amino acid sequence of the third cytoplasmic loop in DA receptor subtypes shows less similarity among the subtypes.
The D2-1ike receptor genes contain several introns in the coding region which give the potential for alternative splicing. Alternative splicing has, in fact, been reported in D2 (Dal Toso et al., 1989; Giros et al., 1989; Grandy et al., 1989; Monsma et al., 1989; Selbie et al., 11989; Chio et al., 1990 ) and D3 receptors Fishburn et al., 1993) . Alternative splicing gives rise to two receptor isoforms. The short form is referred to as "D2-short", D2S or D2(415). The long form [referred to as "D2-1ong", D2L or D2 (444)] contains an additional 29 amino acids in the third cytoplasmic loop. There have been several reports on the CNS distribution of both D2-long and D2-short receptors (Giros et al., 1989; Monsma et al., 1989; Rao, McKelvy, Kebabian & MacKenzie, 1990; Montmayeur et al., 1991) . Although the quantitative results are not consistent, probably due to the different techniques used, it has been agreed generally that D2-1ong is predominantly expressed in all regions of the brain (Falardeau, 1994) . In the human retina, the D2-short receptor has been cloned and localized by in situ hybridization to both the inner and the outer nuclear layers (Stormann, Gdula, Weiner & Brann, 1990; Dearry, Falardeau, Shores & Caron, 1991) . More recently, the D2 receptor has been detected immunocytochemically in retinal Miiller cells in guinea pig and rat (Biedernaann et al., 1995) .
In the D3 receptor gene, several different alternative splicings have been reported depending on the species. In the human D3 receptor, a truncated transcript that differs in the C-terminal region has also been found (Schmauss, Haroutunian, Davis & Davidson, 1993; Liu, Bergson, Levenson & Schmauss, 1994) . In rat, two shorter transcripts of the D3 receptor have been detected . The first transcript encodes a 100-amino acid protein and the second a protein that has an in-frame 54 base pair (bp) deletion which includes the second extracellular loop and a small section of the fifth transmembrane domain. The second transcript was expressed in Chinese hamster ovary (CHO) cells but failed to exhibit any dopaminergic ligand binding activity . Another transcript of the rat D3 receptor with an additional 28 amino acid insertion in the first extracellular loop has also been reported (Pagliusi, Chollet-Daemerius, Losberger, Mills & Kawashima, 1993) . In the mouse D3 receptor, two isoforms differing by 21 amino acids in the putative third cytoplasmic loop have been identified; when expressed, both isoforms could bind dopaminergic ligands in a D3-1ike pharmacological manner (Fishburn et al., 1993) . However, the physiological role of the two D3 receptor isoforms is unknown.
D4 receptors show similar amino acid sequence and pharmacology to D2 and D3 receptors (van Tol et al., 1991; Matsumoto et al., 1995) . The antipsycholotic, clozapine displays higher affinity to D4 than to D2 or D3. In the human retina, D4 receptor mRNA has been found in photoreceptor, inner nuclear and GC layers by in situ hybridization, and D4 receptor inhibition of cyclic AMP has been observed (Cohen et al., 1992) . Expression of the D4 receptor in the human retina has also been confirmed by reverse transcription-polymerase chain reaction (Matsumoto et al., 1995) .
A polymorphic variation of a 48 bp repeat unit in the putative third intracellular loop has been detected in the human D4 receptor (van Tol et al., 1992; Matsumoto et al., 1995) and non-human primate species (Livak, Rogers & Lichter, 1995) . It has also been reported that polymorphism in the human D3 receptor may be related to some forms of psychiatric disease (Crocq et al., 1995) . More recently, genetic polymorphism has been identified at the D2, D3 and D4 DA receptor loci in mice and rats using southern blot hybridization techniques (Scott, Griffin & Luedtke, 1995) .
Signal transduction mechanisms. AlthouLgh both D1/ D1A and D5/D1B receptors stimulate adenylyl cyclase, the D5/D1B receptor has a 10-fold higher affinity to DA (and other agonists such as SKF38393) than the D1/D1A receptor . A signal transduction pathway mediated by D 1/D 1A and D5/D 1B receptors has been widely accepted whereby receptor activation leads to stimulation of adenylyl cyclase via Gs thereby elevating the intracellular concentration of cyclic AMP [for a review, see MacKenzie & Frail (1994) ]. It has also been suggested that Dl-like receptors may activate the inositol phospholipid signalling pathway by stimulating phospholipase C (PLC) in the rat brain (Undie, Weinstock, Sarau & Friedman, 1994) and in fish HCs (Rodrigues & Dowling, 1990) . Dl-like re, ceptors have also been found to mediate mobilization of intracellular Ca 2+ in cRNA-injected Xenopus oocytes (Mahan, Burch, Monsma & Sibley, 1990) and in transfected cells (Frail et al., 1993) thereby also suggesting a link to stimulation of PLC activity (also, Laitinen, 1993) . However, which D1-like subtype(s) stimulate PLC is not yet known and the true nature of the Dl-like stimulation of PLC remains to be determined.
Multiple signal transduction pathways have also been suggested for D2-1ike receptor subtypes (Sokoloff & Schwartz, 1995) . All D2-1ike receptor subtypes (D2-short, D2-1ong, D3 and D4) expressed in transfected cells inhibited adenylyl cyclase in a similar manner through a pertussis-toxin-sensitive G-protein probably belonging to the Gi/Go class (Dal Toso et al., 1989; Falardeau, 1994; McAllister, Knowles, Ward-Booth, Sinclair, Patel, Marwood, Emms, Patel, Smith, Seabrook & Freedman, 1995) . Other signal transduction pathways have been observed, including the following:
1. Stimulation of PLC by D2 receptors (Vallart et al., 1990) . 2. Activation of K + channels leading to reduction in intracellular Ca 2+ concentration by D2 receptors (Lacey, Mercuri & North, 1987; Vallart et al., 1990) . 3. Suppression of high-threshold Ca 2+ current by D2-short (Seabrook et al., 1994a) and D3 receptors (Seabrook et al., 1994b) .
4. Activation of arachidonate release by D2 and D4 receptors (Piomelli et al., 1991) . 5. Stimulation of tyrosine kinase by activation of D2 receptors, leading to mitogenesis (Lajiness, Chio & Huff, 1993) . 6. Na+-dependent extracellular acidification by D4 receptors (Chio et al., 1994) .
We should note, however, that some differences in the physiological responses of given receptor subtypes have been observed when these were functionally expressed in different cellular systems (Falardeau, 1994; Freedman et al. 1994) .
PARKINSON'S DISEASE
Although PD is primarily a disorder of the motor system caused by degeneration of dopaminergic neurons in striatum and substantia nigra, visual defects have also been detected since there is concurrent loss of retinal DA (e.g. Harnois & DiPaolo, 1990; Nguyen-Legros, Harnois, DiPaolo & Simon, 1993) . Current animal models of PD are principally monkeys treated with 6-OHDA or MPTP (1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine).
However, work on lower vertebrates has also contributed significantly to our understanding of the visual consequences of retinal DA deficiency. Unlike other degenerative disease states of the retina (see the following sections), which may involve a variety of neurochemical defects, PD has a well defined dopaminergic locus. However, depletion of retinal DA can have downstream effects which could impinge upon other neurotransmitter systems. Furthermore, it has been found that D1 and D2 receptors may undergo differential sensitivity changes following DA depletion (e.g. Graham, Crossman & Woodruff, 1990; Nowak, Sek & Schorderet, 1991; (1995) . Importantly, characteristics of the visual stimuli used (e.g. intensity, contrast level, spatial frequency) have been found to be crucial in demonstrating PEPG alterations, especially in the early stages of the disease (e.g. Peppe et al., 1992; Peppe et al., 1995; Naarendorp, Hitchock & Sieving, 1993) .
Absolute sensitivity
Absolute sensitivity in PD patients has been studied by recording PERG and FERG responses. Experiments on humans and 6-OHDA-treated monkeys showed that there was loss of absolute sensitivity in the PERGs, dependent upon spatial frequency (Gottlob, Scheider, Heider & Skrandies, 1987; Ghilardi et al., 1989; Bodis-Wollner & Antal, 1995a) [Fig. 3(A) ]. Recordings of VEPs also showed a similar effect (Bodis-Wollner, 1995). Both scotopic and photopic FERG responses were found to be reduced (Ellis et al., 1987) .
The cellular/synaptic basis of the lowered absolute sensitivity in PD is not clear at present. Nevertheless, the reduction in PERG amplitude is in agreement with the findings in mammalian retinae that DA depletion had a generally depressive effect on light-dependent GC activity (Maguire & Smith, 1985; Jensen & Daw, 1986) . One possibility is that the lateral networks of HCs and/or ACs would be more strongly coupled in the and normal patients (circles). The disease is accompanied by attenuation and shift to the left of the peak response both for amplitude and contrast sensitivity measurements. Although similar changes were seen in both transfer functions, these peaked at different spatial frequencies. Modified from Bodis-Wollner and Antal (1995a).
"absence" of DA and this could increase the inhibitory effect on signal transmission in the "through" pathway in the retina. Other modulatory effects directed upon neurotransmitter receptors (e.g. on second-order retinal neurons) may also be involved (Knapp & Dowling, 1987; Schmidt, Kruse & Hatt, 1994; Maguire & Werblin, 1994) .
Spatial contrast sensitivity
Contrast sensitivity (measured by PERG) defines the spatial resolution of the retinal visual system. Most studies agree that contrast sensitivity is impaired in PD patients as well as in the MPTP primate model (Ghilardi, Bodis-Wollner, Onofrj, Marx & Glover, 1988; BodisWollner & Antal, 1995a; Tagliati, Bodis-Wollner & Yahr, 1996) . The impairement is dependent upon spatial frequency and peaks at ca 5 c/deg [ Fig. 3(B) ]. In retinal DA-depleted quail, visual acuity (quantified by the point of intersection on the spatial frequency axis), representing mainly high spatial frequency vision, was also reduced (Lee, 1993; .
The loss of retinal contrast sensitivity (or visual acuity) can most readily be understood in terms of the lateral coupling of HCs and/or ACs. Both HC and AC networks may contribute to the receptive field properties of GCs (Dowling, 1987; Sakai & Naka, 1987; Mangel, 1991) , and thus influence GC activity that is, retinal output. Accordingly, when coupling within either or both of these cellular systems is strengthened and the modulatory influence of DA weakened, the ability of the retinal network to signal spatially distinct stimuli will be impaired.
It would be interesting to note that PERGs and contrast sensitivity functions in normal subjects (as well as in PD patients) peak at different spatial frequencies (Fig. 3) . This would imply (1) that the two functions are controlled by separate lateral networks (e.g. HC vs AC subtypes); and/or (2) that the role of a given network in controlling these functions is optimal in different states of coupling dependent upon the level of DA present. Spatial frequency tuning of the monkey PERG has, in fact, been linked to D2 receptor activation (Tagliati et al., 1994; Stanzione et al., 1995) .
Temporal sensitivity
Several studies have found that the peak latencies in PERG and FERG (as well as VEP) signals are significantly increased and flicker sensitivity decreased in PD or in animal models with DA-depleted retinae (Dyer, Howell & Macphail, 1981; Ellis et al., 1987; Stanzione, Pierelli, Peppe, Stefano, Rizzo, Morocutti & Bernardi, 1989) . In the case of PD, the temporal defects increased as patients progressed from stage 1 to 2 (Ikeda, Head & Ellis, 1994) . Transient PERG delays in humans were seen following overall blockage of DA receptors (Stanzione, Fattapposta, Tagliati, D'Alessio, Marciani, Foti & Amabile, 1990; Bartel et al., 1990) or D2 receptors specificaly (Stanzione, Traversa, Pierantozzi, Semprini, Marciani & Bernardi, 1992) ; elevating endogenous DA levels in normal humans had the opposite effect (Gottlob et al., 1989) .
A number of mechanisms can be considered as possible underlying cause(s) of the temporal defect.
1. Strengthening of HC coupling alone would enhance the negative feedback to photoreceptors, and should, in fact, improve temporal resolution. So, this mechanism may not be the cause. 2. In the absence of DA, AII-AII coupling would be strong and rod-driven transmission in the inner retina would be enhanced in relation to cone-driven activity, thus increasing response latencies. Although, it is generally accepted that DA is indeed involved in the light/dark adaptation of the retina, simply elevating rod-driven activity may not be the only effect of DA depletion, however, since absolute sensitivity has been found to decrease. 3. Another possibility is that some enhancement of AC~BC feedback could occur from the reduction in retinal DA content and the stronge:r coupling of ACs. If this feedback interaction is positive, then temporal resolution could suffer. In fact, Oliver et al. (1987) has shown that DA has a delaying effect on the latency of the b-wave in the rabbit retina, consistent with involvement of ON-centre BCs. Furthermore, oscillatory potentials, which are thought to be generated by feedback circuits in the inner retina, have been found to be increased in amplitude in 6-OHDA-treated retinae of frog (Citron et al., 1985) and chicken , as would be expected from this hypothesis.
Colour vision
Since DA affects photoreceptor-HC transmission and HC functioning, which may contribute to chromatic processing in the retina (Djamgoz & Yamada, 1992; Djamgoz, Fitzgerald & Yamada, 1996) , some abnormality of colour discrimination in PD may be expected. However, the available data are not consistent in this respect and both normal and impaired colour discrimination has been reported in PD patients (Kuper-Smith, Shakin, Siegel & Liebermann, 1982; Smith, Pokorny & Pass, 1985; Price, Feldman, Adelberg & Kayne, 1992; Barbato, Parzold, Kuhn, Muller & Przuntek, 1994; Buttner et al., 1995) . This variability could be related to the degree of retinal DA loss, and hence, the part of the retinal network affected in different PD patients. Interestingly, where a colour vision defect has been seen, this has been found to involve blue-sensitive (B-) cones (Hang, Kolle, Trenkwalder, Oertel & Paulus, 1995) . Furthermore, B-cone function has also been found to be reduced in cocaine-dependent patients (Roy, Roy, Williams, Weinberger & Smelson, 1997) , consistent with inhibition of the DA transporter by cocaine (Altman, 1996) .
The synaptic basis of colour vision loss in PD, if any, is not clear at present. In the specific case of B-cone dysfunction, the effect could be related to certain cell types with selective B-cone input in some mammalian retinae [e.g. HCs (Ahnelt & Kolb, 1994) , BCs (Mariani, 1984) and GCs (Dacey & Lee, 1994) ], coupled with the well known influence of DA on cone ~ HC synaptic transmission, as reviewed above. In addition, NADPH diapharase, a marker for NO synthase, has been associated with B-cones in the mammalian retina (Petry & Murphy, 1995) , and NO and DA have been shown to interact (Djamgoz et al., 1995a) .
AGEING
Ageing of the human retina is accompanied by a number of cellular and corresponding neurochemical changes, including loss of photoreceptors and GCs, and probably also other, intermediary neurons (e.g. Marshall, Grindle, Ansell & Brown, 1979; Katz & Robinson, 1986; Kilbride, Hutman, Fishman & Read, 1986; Fite & Bengston, 1989; Hodos, Miller, Fite, Porciatti, Holden & Lee, 1991a; Curcio & Drucker, 1993; Curcio, Millican, Allen & Kalina, 1993; Gao & Holyfield, 1992; Weisse, 1995) . Comparable effects have also been seen in retinae of Alzheimer's disease (AD) patients (e.g. Katz, Rimmer, Iraqui & Katzman, 1989; Cronin, Corkin, Rizzo, Cohen, Crowdon & Banks, 1991) . Visual pathophysiology of ageing has been studied using electrophysiological and psychophysical techniques in humans as well as in model mammals like monkeys and rats. Rodents have been used as good models for human ageing studies (Hazzard, 1991) . Interestingly, Hodos (1991) has advanced the view that birds (e.g. pigeons, quail) could also offer several advantages as animal models of visual ageing due to their short life spans and possible sexual contrasts in ageing patterns which may be possible to relate to endocrinological differences such as Ca 2+ homeostasis and egg production. The effects of ageing on human vision have been reviewed previously by Weale (1986 Weale ( , 1991 Weale ( , 1992 and Kline ( 1991) .
Ageing has been found to be accompanied by a number of defects in visual function in a variety of animal models and humans, some quite similar to those seen in PD patients, including the following:
1. Impairement of spatial contrast sensitivity, with or without a change in visual acuity (Owsley, Sekuler & Siemsen, 1983; Hodos, Miller & Fite, 1991b; Owsley & Burton, 1991; Porciatti, Burr, Morrone & Fiorentini, 1992; Burton, Owsley & Sloane, 1993; Muir et al., 1996; Lee, Holden & Djamgoz, 1997) [ Fig. 4(B) ]. 2. Slowness of visually-evoked responses (BodisWollner, Marx, Mitra, Bobak, Mylin & Yahr, 1987; Kline, Scialfa, Lyman & Schieber, 1990; Porciatti, Burr, Fiorentini & Morrone, 1991a; Partenen, Hartikainen, Kononen, Jousmaki, Soininen & Riekkinen, 1994; Tachibana, Toda & Sugita, 1992 "young" (3-6 months old) and "old" (16 months or older) male quail ; and (A) young male quail before and after depletion of retinal dopamine by 6-OHDA treatment. Each data point represents mean±standard error (n=6-16). The data show that ageing was accompanied by a significant loss of contrast sensitivity in the spatial frequency range 0.2-2 c/deg (B). A similar change, but extending to higher frequencies was seen following retinal dopamine depletion (A). Modified from (B) ; (A) and .
. . Weleber, 1981; Martin & Heekenlively, 1982; Wright, Williams, Drasdo & Harding, 1985; Trick, Trick & Haywood, 1986; Celesia, Kaufman & Cones, 1987) . Loss of both rod and cone absolute sensitivities has been seen (Pulos, 1989; Sturr & Hannon, 1991; Cideciyan & Jacobson, 1996; Sturr, Zhang, Taub, Hannon& Jackowski, 1997) . Impairement of light/dark adaptatiion (Birren & Shock, 1950; McFarland, Domey, Warren & Ward, 1960; Stuff &Hannon, 1991; McMurdo & Gaskell, 1991) . Some impairement of colour vision (Weale, 1991) . Comparable visual defects have aJso been seen during AD (e.g. Mendez, Tomsak & Remler, 1990; Tobimatsu, Hawada, Okayama, Fukui & Kato, 1994) . In some cases, any physical change in the the ocular pathway could be ruled out as a contributory effect (Sloane, Owsley & Alvarez, 1988; Cideciyan & Jacobson, 1996) .
It would be important to emphasize that ageing is an extremely heterogenous process with individuals ageing differently, so not all changes may occur simultaneously, if at all. This is true also regarding the apparent parallel with PD (Mestre, Blin, Serratrice & Pailhous, 1990) .
A critical study on humans using psychophysically equivalent stimuli and PERG measurements concluded that the ageing loss in contrast sensitivity arises subsequent to photoreceptors but before or at the level of GCs (Muir et al., 1996) . Many of the age-related visual defects noted above can, in fact, be explained in terms of abnormalities in retinal dopaminergic function, as suggested already above for PD. In particular, there is some evidence for dysfunction of the retinal dopaminergic system during senescence in the mammalian retina. Receptor binding studies have demonstrated significant elevation in D1 receptor binding in the senescent rat (Giorgi, Pibiri, Dal Toso & Ragatzu, 1992a) , which was attributed to a reduction in receptor degradation (Giorgi, Pibiri, Dal Toso, Toffano & Biggio, 1992b) . Furthermore, in normal adult rats the number of D1 receptors was significantly augmented (upregulated) during prolonged dark adaptation, but this mechanism was absent in the senescent adult (De Montis, Porceddu, Pepitoni, Serra & Biggio, 1988) . The total retinal DA content of rhesus monkeys did not change significantly as the animals progressed from normal adulthood to ageing (Iuvone, Tigges, Fernandes & Tigges, 1989) . On the otlher hand, a population study of catecholaminergic cells in quail retinae using the Faglu fluorescence method revealed up to some 50% loss of cells during ageing (Lee, 1993; . Significant reduction has been observed in aged rat retinae as regards DA transport and release (Hankins, I995b, c) . In human substantia nigra, also, DA receptor mRNA was found to decrease precipitously with age (Bannon, Poosch, Xia, Goebel, Cassin & Kapatos, 1992) . Importantly, Lee (1993) and showed that depletion of retinal DA by 6-OHDA treatment in young male and female quail produced some of the effects seen during ageing, that is, loss of contrast sensitivity and prolongation of response latency, as measured by PERG [Fig. 4 ]. In addition, however, reductions of visual acuity and maximum response amplitde also were seen (Lee, 1993) . This would imply that loss of dopaminergic function during ageing may not be as great as in PD or experimental DA depletion. In any case, retinal ageing/ degeneration probably involves other neurochemical changes as well (Rattan & Derventzi, 1991; Eldred, 1993; Jensen, 1995) .
RETINITIS PIGMENTOSA
Dystrophies of the outer retina of the human comprise a wide range of genetically determined pathologies, which vary both in their mode of inheritance and the specific functional pattern of their visual toss (Bird, 1995) . The majority of these disease entities are associated with functional loss principally in the ,;cotopic rod system resulting in peripheral vision dysfunction and are known collectively as RP. In some cases, particularly in the late stages, some forms of outer retinal dystrophies can affect both rod and cone photoreceptors. Patients with autosomal dominant RP due to point ~autatation in the rhodopsin molecule (see below), are typified by a log unit loss in absolute rod sensitivity in the early stages of the disease, associated with abnormal dark adaptation and variable cone dysfunction in the latter stages (Jacobson et at., 1991) . Collectively, RP a.s a group of hereditary retinal degenerations of mixed aetiology, represents the most frequent human retinal dystrophies with an estimated occurrence of 1:3000-5000 (Heckenlively, 1988) . Advances in molecular biology have enabled the elucidation of numerous genetic subtypes of RP. Amongst certain subtypes of the disease, are phenomena which promote fundamental questions regarding the underlying pathophysiology which ultimately leads to photoreceptor cell loss. For example, in those cases of autosomal dominant RP due to point mutation or deletion in the rhodopsin gene, in addition to the predicted loss of rod function, some phenotypes express near complete loss of cone cells beyond the central 10 ° in the later stages of the disease (Jacobson et al., 1991) . There is increasing evidence that the defect caused by the mutation may not result in direct cell loss. Furthermore, in the studies of animal models (see below), including the "Royal College of Surgeons" (RCS) rat and "retinal degeneration slow" (rds) mouse, it is now known that the ultimate loss of photoreceptors occurs specifically through apoptosis (Chang, Hat & Wong, 1993; Tso et al., 1994) . Thus, in the case of the RCS rat where the fundamental defect is located at the retJinal pigment epithelium (RPE), some underlying pathophysiology may lead to controlled cell death in photoreceptors. Similarly in human RP, point mutations in the rhodopsin molecule must in some way be linked indirectly to cone photoreceptor degeneration in those patients who show delayed photopic loss in the peripheral reti:aa. It may be of great importance to understand these interactions since this would raise the possibility of reducing this indirect, but very significant, damage by intervention downstream of the genetic abnormality. Whilst these effects could revolve around local interactions betweer~ photoreceptots, the RPE and the extracellular matrix, it cannot be ruled out that they may include more complex mechanisms and involve the neural retina.
Animal models of retinal dystrophy
A variety of hereditary retinal degenerations have been observed in a wide range of animal species, including mouse, rat, cat, dog and horse (Voaden, lCl88) . Many of these involve well defined pathologies, some of which resemble closely the apparent aetiology of the human RP. Viewed collectively, the results of extensive studies on the animal models suggest that the underlying pathophysiology may involve multiple factors, some of which are certainly downstream of the genetic abnormality. In this review, we have restricted our attention to two well studied rodent models of retinal dystrophy, the RCS rat and the rds mouse.
In the case of the RCS rat, an autosomal recessive defect is manifested ultimately by a complete loss of rod photoreceptors. In this model, photoreceptor pathology begins at ca 24 days, and the animal eventually becomes blind at ca 60 days (Dowling & Sidman, 1962) . It is clear that the aetiology of hereditary retinal degeneration in the RCS rat is a failure of the RPE to phagocytose the shed outer segment discs of the photoreceptors (Bok & Hall, 1971) , which initially results in the elongation of photoreceptors, followed by the accumulation of debris in the subretinal space and ultimately the apoptosis of rod cells (Tso et al., 1994) . This view is supported further by the evidence that transplantation of normal RPE cells into the subretinal space at an early stage may partially rescue photoreceptors in the RCS rat (Sheedlo et al., 1989) . As yet, largely because of the lack of a defined genetic locus, it remains unclear whether this form of retinal degeneration has any closely related human homologue.
In the rds mouse strain, a specific membrane photoreceptor protein, peripherin, is defective through a specific point mutation. Mice which are both homozygous and heterozygous for the mutation show a slow, progressive loss of photoreceptor cells. The peripherin protein has been localized along the rim structures of disk membranes in both rod and cone photoreceptors (Arikawa, Molday & Molday, 1992) . Abnormalities in this protein appear to result in improper construction of new disk membranes and/or promote abnormalities in photoreceptor shedding. The defective rds-peripherin gene has been identified (Travis, Brennan, Danielson, Kozak & Sutcliffe, 1989; Connell, Bascom, Molday, Reid, Mclnnes & Molday, 1991) . In addition specific human peripherin gene defects are now known to be associated with some forms of autosomal dominant RP (Farrar, Jordan & Kumar-Singh, 1993) and possibly some forms of adult viteliform macular dystrophy (Wells, Wroblewski & Keen, 1992) .
Evidence for dopaminergic abnormalities in the dystrophic retina
Whilst studying a diurnal variation in the electroretinographic c-wave in the RCS rat, Hawlina et al. (1992) also provided strong evidence for a retinal MEL abnormality. It was shown that young, pre-degenerate dystrophic retinae contained some two-fold higher levels of cellular MEL than control retinae in the night-time phase. Given the intimate contra-regulatory roles of DA and MEL in retinal physiology, as mentioned above (Dubocovich, 1989) , this prompted the examination of potential abnormalities in the retinal DA pathways. Thus, electrophysiological studies in the RCS rat, performed in the critical period prior to the onset of retinal degeneration, have provided direct evidence for early abnormalities in the function of DA pathways (Hankins & Ikeda, 1994) .
These studies were performed on retinae isolated from age-matched control and dystrophic animals at postnatal day (pd) 17-24. In the RCS rat, exogenous DA applied to both the control and dystrophic retinae was found to depolarize HCs and to reduce the response to a broadfield light stimulus, entirely consistent wit]~ the responses previously reported in the normal adult rat (Hankins & Ikeda, 1991; Fig. 5 ). However, D1 antagonists, such as SCH 23390, clearly differentiated the I:wo groups of animals. Thus, whilst the application SCH 23390 hyperpolarized HCs and enhanced the response to a broad-field flash in the control retinae [ Fig. 5(A) ], it had no effect on HCs in the dystrophic retinae [ Fig. 5(B) ].
The results of these studies in the RCS rat suggest that, whilst there is a normal postsynaptic response to exogenous DA, there is little or no endogenous DA released in the neural retina in the critical period that precedes degeneration. Furthermore, these studies also examined the effects of DA antagonists on HCs in control retinae recorded in the presence of excess exogenous MEL and found that the cells also failed to respond to SCH 23390 [ Fig. 5(C) ]. Thus, the responses of the HCs to dopaminergic drugs in the control retinae perfused with excess MEL were similar to those of cells in the dystrophic retinae. The observed lack of endogenous A I dopaminergic activity in the dystrophic retinae was not 12--simply due to the absence of dopaminergic neurons, since 10 ] the density and morphology of these cells seemed ~, i identical in the control and dystrophic groups (Hankins ~ 8 & Ikeda, 1994) . This conclusion further supported the ~ = 6
finding that retinal tissue content of DA is normal in the ~ . dystrophic rat and mice throughout the disease (Frucht, ~ 4 Vidauri & Melamed, 1982; Kato, Sugawara & Negishi, ~ 2 " 1981) , but DA does not seem to be available for any biological function (Nir & luvone, 1994) . 0 -Having established the retinal DA deficiency in the dystrophic RCS rat (Hankins & Ikeda, 1994) , experiments were also performed to explore whether ~his deficit was associated with abnormalities in HC receptive field properties. This was examined by recording from HCs stimulated by simple small spots of light which could be B displaced left and right of the cells' receptive field (Fig.  12-6 ). These experiments established that the receptive fields 10 -of HCs in the dystrophic animals were indeed signifi-~-cantly broader than those observed in the age-matched ~ 8 [ controls [ Fig. 6(A) ]. Furthermore, such abnormally broad ~ 6 -receptive fields could be replicated in the normal control ~= -retinae by the presence of excess exogenous MEL [ Fig. E 4 -6(B)]. These results are consistent with the absence of a w functional DA system in the dystrophic animals, which ~ 2-leads to abnormally strongly coupled HCs with anom-0 alously broad receptive field profiles.
The general hypothesis that the DA pathway is dysfunctional in the RCS rat has gained a more general significance from the results of studies on the rds mouse retina (Nir & Iuvone, 1994) . In these experiments, rds retinal DA levels were found to be normal, but there was little or no turnover, or light-induced increase in DA synthesis. These findings led the authors to conclude that DA pathways are not functional in the rds mouse retina. It should also be emphasized, as is the case of the RCS rat, that these dopaminergic abnormalities were apparent prior to pathological damage of photoreceptors.
In conclusion, whilst the genetic origin of these two forms of hereditary dystrophy are quite different, both show very similar functional deficits in the neural retina prior to photoreceptor cell loss. 
Are dopaminergic deficits significant factors in retinal dystrophy ?
Evidence from two of the most extensively studied animal models of hereditary retinal degeneration, the RCS rat and the rds mouse, suggested that the: retinal DA pathways are indeed abnormally and chronically suppressed. In both cases, abnormal physiological changes were observed prior to the commencement of pathological degeneration and photoreceptor cell loss. The aetiological locus of retinal degeneration in 1]ae RCS rat appears to be located in the RPE (Bok & Hall, 1971; Mullen & LaVail, 1976) . Although, accordingly, transplantation of normal RPE cells into the predegenerate rat could rescue photoreceptor cells (Sheedlo et al., 1989;  Lopez, Gouras, Kjeldbye, Sullivan, Reppucci, Brittis, Wapner & Goluboff, 1989) , there has been a suggestion that such rescue may be related to the surgically evoked retinal detachment (Silverman & Hughes, 1990) . However, it remains likely that early photoreceptor abnormalities result in upregulated MEL synthesi.s (Hawlina et al., 1992) . Such elevated levels of MEL, when released into the neural retina, would inhibit retinal DA release and turnover. This agrees with the finding that the "dystrophy-like" deficit in DA release can be mimicked in the control retina by exogenous MEL (Hankins & Ikeda, 1994) . Such an imbalance would further be exaggerated by neurochemical feedback, since chronic suppression of DA release would disinhibit MEL release from photoreceptors via a reduction in D4 receptor activation at the photoreceptor outer segments (Iuvone & Besharse, 1986; Cohen et al., 1992) . The loss of activity in the retinal DA system will have a number of functional consequences, including abnormal spatial summation in the HCs and thus abnormal centre-surround organization in the outer plexiform layer. Furthermore, imbalance in the MEL-DA system will disrupt the functional transition from day to night vision which involves a number of discrete retinal mechanisms which may affect the balance of rod/cone activity. Such changes may thus be associated with abnormal dark adaptation and additional changes in rod sensitivity which are symptomatic of many forms of RP. Both of these effects on visual performnce may be involved in the functional visual loss that occurs in early retinal degeneration.
CONCLUDING REMARKS
In conclusion, retinal DA plays an important role in a variety of visual functions in vertebrates including man. Consequently, impairement of dopaminergic function in the retina, occurring either specifically (e.g. as in PD) or as a part of a general degenerative process (e.g. as in RP, AD or normal ageing), leads to a number of visual defects involving spatial and temporal vision, as well as absolute sensitivity control and colour vision. Many of these defects, including some arising in PD, have successfully been treated, at least temporarily, by levodopa administration (e.g. Domenichi, Trimarchi, Piccolino, Fiorentini & Maffei, 1985; Ellis et al., 1987; Gotlob et al., 1989; Masson, Mestre & Blin, 1993; Hutton, Morris & Elias, 1993; Buttner, Kuhn, Patzold & Przuntek, 1994b , Buttner et al., 1995 Peppe et al., 1995; Mestre, Blin, Vandenbrand, Azulay & Serratrice, 1996) .
It remains to be resolved whether abnormalities in DA pathways are instrumental in retinal degeneration, although they certainly precede the photoreceptor loss in both the RCS rat and the rds mouse. This question could be resolved by examining whether MEL antagonists, or indeed DA agonists, could be useful in arresting or retarding pathological retinal degeneration. This may well be the case since MEL itself has been shown to exacerbate photoreceptor cell loss in the RCS retina (Bubenik & Purtill, 1980) . Ophthalmologically, the appearance of fundus in several non-genetic disease states can often be mistaken for phenotypic RP. Whilst this can present problems in clinical diagnosis, such phenocopies of RP, acquired through the side-effects of drug therapy, may present clues to the pathophysiology underlying retinal degeneration. For example, both chloroquine and the phenothiazine neuroleptic thioridizine, can give rise to a pigmentary retinopathy and night blindness associated with pigmentary changes in the fundus, and interestingly many phenothiazines are effective DA antagonists known clinically to have extrapyramidal side-effects. However, the development of selective MEL antagonists has proved somewhat problematic. Nevertheless, should it prove to be the case that imbalances in DA-MEL pathways are significant pathophysiological factors in general retinal dystrophy and acquired retinal degeneration, then thiis may become a productive avenue to explore in relation to therapeutic intervention.
Although several different visual dysfunctions can clearly result from depletion of retinal DA during degeneration of the tissue, the nature of the underlying synaptic defects are not always well understood. Furthermore, since DA is instrumental in controlling the efficiency of other major neurochemical systems (e.g. GABA, glycine, glutamate) in the retina, "knock-on" effects could also occur and contribute to the resulting visual dysfunctions. It has been suggested that the magnocellular system may suffer more damage in PD than do parvocellular cells (Regan & Maxner, 1987; Hunt et al., 1995) . On the whole, however, the synaptic structuring of functionally distinct GC receptive fields and degree of their susceptibility to dopaminergic degeneration are not known in detail. Another unknown is the potential role of an alternative pathway proposed in the mammalian retina (DeVries & Baylor, 1995) for signal flow from rod photoreceptors to GCs involving the following chain:
rod > cone > cone-BC---* GC, relative to the well established system: rod ~ rod-ON-BC > AII-AC---~ cone-BC > GC.
Finally, an important aspect of the synaptic organization of the vertebrate retina is its plasticity, which is well known to occur in lower vertebrate,; (Wagner & Djamgoz, 1993) . Interestingly, some studies have suggested that neuronal plasticity is also apparent in retinae of dystrophic (RCS) rat (Li, Kljavin & Milam, 1995) and rds mouse (Jansen & Sanyal, 1992) . It is likely, therefore that retinal degeneration could involve also long-term complex synaptic changes incl[uding receptor sensitivity and/or expression (Ogawa & Asanuma, 1991; Joyce & Murray, 1994; Guttman, 1994) . Clearly, much more remains to be done not only on the basic neurobiology of retinal DA, but also as regards the pathophysiology and molecular biology of the dopaminergic system during retinal degenerations.
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